TNDM Tandem Diabetes Care Inc

Price (delayed)

$80.56

Market cap

$5.05B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.39

Enterprise value

$5.24B

Sector: Healthcare
Industry: Medical Devices

Tandem Diabetes Care is a public US medical device manufacturer based in San Diego, CA. The company develops medical technologies for the treatment of diabetes and specifically insulin infusion therapy. ...

Highlights

Tandem Diabetes Care's quick ratio has soared by 164% YoY and by 4% from the previous quarter
TNDM's revenue is up by 37% year-on-year and by 9% since the previous quarter
The company's equity has surged by 51% YoY but it fell by 14% QoQ
The net income has decreased by 48% YoY but it has increased by 29% from the previous quarter
The debt has increased by 40% from the previous quarter
Tandem Diabetes Care's gross margin has decreased by 2.4% YoY

Key stats

What are the main financial stats of TNDM
Market
Shares outstanding
62.64M
Market cap
$5.05B
Enterprise value
$5.24B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
16.07
Price to sales (P/S)
9.28
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
9.68
Earnings
Revenue
$541.94M
EBIT
-$12.32M
EBITDA
-$211,000
Free cash flow
$49.82M
Per share
EPS
-$0.39
Free cash flow per share
$0.8
Book value per share
$5.01
Revenue per share
$8.68
TBVPS
$12.08
Balance sheet
Total assets
$754.27M
Total liabilities
$440.86M
Debt
$318.63M
Equity
$313.41M
Working capital
$558.29M
Liquidity
Debt to equity
1.02
Current ratio
6.4
Quick ratio
5.68
Net debt/EBITDA
-937.6
Margins
EBITDA margin
0%
Gross margin
52.3%
Net margin
-4.5%
Operating margin
0.4%
Efficiency
Return on assets
-3.6%
Return on equity
-7.7%
Return on invested capital
-1.8%
Return on capital employed
-1.9%
Return on sales
-2.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

TNDM stock price

How has the Tandem Diabetes Care stock price performed over time
Intraday
0.07%
1 week
-11.8%
1 month
-8.44%
1 year
-11.46%
YTD
-15.8%
QTD
-8.71%

Financial performance

How have Tandem Diabetes Care's revenue and profit performed over time
Revenue
$541.94M
Gross profit
$283.55M
Operating income
$2.38M
Net income
-$24.56M
Gross margin
52.3%
Net margin
-4.5%
The operating income has soared by 130% QoQ and by 112% YoY
The operating margin has soared by 125% from the previous quarter and by 108% YoY
The net income has decreased by 48% YoY but it has increased by 29% from the previous quarter
TNDM's revenue is up by 37% year-on-year and by 9% since the previous quarter

Growth

What is Tandem Diabetes Care's growth rate over time

Valuation

What is Tandem Diabetes Care stock price valuation
P/E
N/A
P/B
16.07
P/S
9.28
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
9.68
Tandem Diabetes Care's EPS has decreased by 39% YoY but it has increased by 30% from the previous quarter
The company's equity has surged by 51% YoY but it fell by 14% QoQ
TNDM's price to book (P/B) is 17% less than its last 4 quarters average of 19.3
TNDM's revenue is up by 37% year-on-year and by 9% since the previous quarter
The P/S is 29% lower than the last 4 quarters average of 13.1 but 19% higher than the 5-year quarterly average of 7.8

Efficiency

How efficient is Tandem Diabetes Care business performance
The return on invested capital has surged by 80% year-on-year and by 60% since the previous quarter
Tandem Diabetes Care's ROS has soared by 51% from the previous quarter and by 45% YoY
The return on assets has increased by 39% since the previous quarter and by 35% year-on-year
TNDM's ROE is up by 35% from the previous quarter and by 17% YoY

Dividends

What is TNDM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TNDM.

Financial health

How did Tandem Diabetes Care financials performed over time
The total assets is 71% greater than the total liabilities
Tandem Diabetes Care's quick ratio has soared by 164% YoY and by 4% from the previous quarter
TNDM's current ratio has surged by 127% year-on-year and by 4.2% since the previous quarter
The company's debt to equity has surged by 65% QoQ
The company's equity has surged by 51% YoY but it fell by 14% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.